Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

1. Molina-Collada, J.
2. Alonso, F.
3. Otero, L.
4. Bohórquez, C.
5. Díaz Torné, C.
6. Pérez García, C.
7. Blanco Madrigal, J.M.
8. Vela, P.
9. Álvaro-Gracia, J.M.
10. Castrejón, I.